Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06459323
Other study ID # Cholecystectomy timing
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date March 1, 2025
Est. completion date May 1, 2026

Study information

Verified date June 2024
Source Assiut University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Compare outcomes of patients undergoing early laparoscopic cholecystectomy within and after72 hours of symptoms.


Description:

Laparoscopic cholecystectomy (LC) is the mainstay treatment of acute cholecystitis. However, it remains a challenging procedure with low but significant risks of major complications such as bile duct injury increasing as the severity of AC progresses. New Guidelines suggest that laparoscopic cholecystectomy should preferably be performed within 72 hrs of symptom onset but has acknowledged that this may not be always possible in practice. Hence, it recommends that patients presenting after 72 h of symptom onset may still benefit from laparoscopic cholecystectomy in selected patients Studies found that it is imperative to convert to open cholecystectomy when it is deemed unsafe to dissect the Calot's triangle may occur even within or beyond first 72 hrs of attck symptoms. studies found a statistically longer mean total length of hospitalization, operation time and intraoperative blood loss for LC performed beyond 72 h, this did not translate into clinically significant adverse outcomes such as an increase in perioperative morbidity or the need for blood transfusion. After 72 h, chronic inflammation and fibrosis set in resulting in more technically demanding and longer surgeries.Studies show differing results reporting longer operation times for laparoscopic cholecystectomy beyond 72 h, due to stiffer tissues that cannot be bluntly dissected during the subacute phase of tissue inflammation. However, other studies did not report any difference in operation times between both groups.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 20
Est. completion date May 1, 2026
Est. primary completion date March 1, 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: 1. Patients with acute cholecystitis within and after 72 hours. 2. Patients over 18 years. 3. Patients with no common bile duct stones based on imaging and biochemical criteria 4. Fit for surgery. Exclusion Criteria: 1. Patients not fit for surgery 2. Patients with Pancreatitis. 3. Significant medical disease rendering patient unfit for Laparoscopic surgery (e.g. Uncontrolled Diabetes Mellitus, Chronic Pulmonary Disease, significant Cardiac Disease)

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Laparoscopic cholecystectomy
Laparoscopic cholecystectomy

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Outcome

Type Measure Description Time frame Safety issue
Primary Bile duct injury , intraoperative bleeding and operative time Evaluate bile duct integrity, calculate amount of blood loss and operative time from the start till the end One week
See also
  Status Clinical Trial Phase
Completed NCT04156711 - Remote Ischemic Preconditioning in Patients Undergoing Acute Minor Abdominal Surgery N/A
Recruiting NCT02130245 - Acute Cholecystitis: Early Versus Delayed Laparoscopic Cholecystectomy; Randomized Prospective Study N/A
Completed NCT01942356 - Evaluation of Closed-loop TIVA Propofol, Sufentanil and Ketamine Guided by BIS Monitor N/A
Completed NCT04995380 - Validation and Comparison of Scores for Prediction of RIsk for Post-operative Major Morbidity After Cholecystectomy in Acute Calculous Cholecystitis (SPRIMACC)
Completed NCT03999645 - Is it Safe to do Laparoscopic Cholecystectomy for Acute Cholecystitis up to Seven Days? N/A
Completed NCT03296280 - Evaluation of Implementation of a National Point-of-Care Ultrasound Training Program
Completed NCT03002051 - EUS-guided Transenteric Drainage With a Novel Lumen-apposing Metal Stent N/A
Completed NCT00447304 - Acute Cholecystitis - Early Laparoscopic Surgery Versus Antibiotic Therapy and Delayed Elective Cholecystectomy Phase 3
Completed NCT04346550 - Comparison of Morbidity After Laparoscopic Cholecystectomy for Acutely Inflamed Gall Bladder With and Without Drain N/A
Active, not recruiting NCT04197908 - EUS-guided Gallbladder Drainage Instead of Laparoscopic Cholecystectomy for Acute Cholecystitis. A Feasibility Study. N/A
Completed NCT02027402 - Effects of Drainage in Laparoscopic Cholecystectomy N/A
Not yet recruiting NCT01706068 - Transient ECG Changes in Patients With Acute Biliary Disease N/A
Enrolling by invitation NCT04633512 - Safety and Feasibility of ActivSightTM in Human N/A
Completed NCT04672902 - Treatment of Mirizzi Syndrome
Completed NCT03122054 - Early Versus Delayed Cholecystectomy N/A
Recruiting NCT05732480 - Influence of Gut Microbiome in Gallstone Disease
Completed NCT04308265 - Scoring System in Acute Calculous Cholecystitis
Not yet recruiting NCT06287112 - Prevention of Acute Cholecystitis With ETGBD N/A
Recruiting NCT05709548 - Use of Indocyanine Green in Acute Cholecystitis Phase 4
Enrolling by invitation NCT06364865 - AE05ML Device for ML Hem-o-lok Polymer Clip Delivery in Laparoscopic Surgical Procedures Observational Registery Study